Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lusher

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|December 17, 2009
Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701HDennis J van de Wijngaart, Michel Molier, Scott J Lusher, et al.
Annals of Internal Medicine|July 1, 1990
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study GroupP M Mannucci, K Schimpf, D B Brettler, et al.
Bulletin of the World Health Organization|January 1, 1995
Modern treatment of haemophiliaE Berntorp, V Boulyjenkov, D Brettler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2011
Standardization of thromboelastography: a report from the TEG-ROTEM working groupM Chitlur, B Sorensen, G E Rivard, et al.
Clinical Pharmacology and Therapeutics|June 1, 1994
Pharmacokinetics and pharmacodynamics of recombinant factor VIIaC M Lindley, W T Sawyer, B G Macik, et al.
Lancet (London, England)|September 18, 1993
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune statusS V Seremetis, L M Aledort, G E Bergman, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1993
Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I studyB G Macik, C M Lindley, J Lusher, et al.
Journal of Chemical Information and Modeling|January 27, 2017
3D-e-Chem-VM: Structural Cheminformatics Research Infrastructure in a Freely Available Virtual MachineRoss McGuire, Stefan Verhoeven, Márton Vass, et al.
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1975
Scanning electron microscopy of human reproductive physiologyE S Hafez, M I Barnhart, H Ludwig, et al.
The Journal of Biological Chemistry|April 27, 2012
X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroidsScott J Lusher, Hans C A Raaijmakers, Diep Vu-Pham, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|December 17, 2009
Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701HDennis J van de Wijngaart, Michel Molier, Scott J Lusher, et al.
Annals of Internal Medicine|July 1, 1990
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study GroupP M Mannucci, K Schimpf, D B Brettler, et al.
Bulletin of the World Health Organization|January 1, 1995
Modern treatment of haemophiliaE Berntorp, V Boulyjenkov, D Brettler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2011
Standardization of thromboelastography: a report from the TEG-ROTEM working groupM Chitlur, B Sorensen, G E Rivard, et al.
Clinical Pharmacology and Therapeutics|June 1, 1994
Pharmacokinetics and pharmacodynamics of recombinant factor VIIaC M Lindley, W T Sawyer, B G Macik, et al.
Lancet (London, England)|September 18, 1993
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune statusS V Seremetis, L M Aledort, G E Bergman, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1993
Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I studyB G Macik, C M Lindley, J Lusher, et al.
Journal of Chemical Information and Modeling|January 27, 2017
3D-e-Chem-VM: Structural Cheminformatics Research Infrastructure in a Freely Available Virtual MachineRoss McGuire, Stefan Verhoeven, Márton Vass, et al.
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1975
Scanning electron microscopy of human reproductive physiologyE S Hafez, M I Barnhart, H Ludwig, et al.
The Journal of Biological Chemistry|April 27, 2012
X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroidsScott J Lusher, Hans C A Raaijmakers, Diep Vu-Pham, et al.
Pageof 5